BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26655504)

  • 1. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
    Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
    J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.
    Ren F; Wu H; Lei Y; Zhang H; Liu R; Zhao Y; Chen X; Zeng D; Tong A; Chen L; Wei Y; Huang C
    Mol Cancer; 2010 Apr; 9():81. PubMed ID: 20403181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
    Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
    Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
    Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
    J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
    Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
    J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
    Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
    Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
    Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
    IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
    Jiang X; Sun Q; Li H; Li K; Ren X
    Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
    Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
    Nat Commun; 2013; 4():1790. PubMed ID: 23653202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma.
    Xu Z; Gong J; Wang C; Wang Y; Song Y; Xu W; Liu Z; Liu Y
    Oncol Rep; 2016 Oct; 36(4):2236-44. PubMed ID: 27572934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
    Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
    Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
    Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
    Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and expression of a tumor-associated antigen in esophageal squamous cell carcinoma.
    Gao HJ; Yue ZG; Zheng M; Zheng ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):244-8. PubMed ID: 22776657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
    Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
    Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.
    Ohba S; Johannessen TA; Chatla K; Yang X; Pieper RO; Mukherjee J
    Cell Rep; 2020 Apr; 31(2):107518. PubMed ID: 32294440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation reveals how phosphorylation of tyrosine 26 of phosphoglycerate mutase 1 upregulates glycolysis and promotes tumor growth.
    Wang Y; Cai WS; Chen L; Wang G
    Oncotarget; 2017 Feb; 8(7):12093-12107. PubMed ID: 28076845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGAM1 regulates the glycolytic metabolism of SCs in tibetan sheep and its influence on the development of SCs.
    An X; Li T; Chen N; Wang H; Wang X; Ma Y
    Gene; 2021 Dec; 804():145897. PubMed ID: 34418471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate.
    Oslund RC; Su X; Haugbro M; Kee JM; Esposito M; David Y; Wang B; Ge E; Perlman DH; Kang Y; Muir TW; Rabinowitz JD
    Nat Chem Biol; 2017 Oct; 13(10):1081-1087. PubMed ID: 28805803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
    Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
    Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.